Bristol-Myers Squibb (BMY) News Today $59.22 -0.05 (-0.08%) (As of 11/29/2024 05:27 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Bellevue Group AG Purchases New Position in Bristol-Myers Squibb (NYSE:BMY)Bellevue Group AG acquired a new stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 36,825 shares of the biopharmaceutical company's stock, valued at approximately $1,905,000. A nuDecember 1 at 7:13 AM | marketbeat.comBRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Has $17.50 Million Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp cut its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 12.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 338,232 shares of the biopharmaceuticaDecember 1 at 6:32 AM | marketbeat.comFred Alger Management LLC Acquires 60,797 Shares of Bristol-Myers Squibb (NYSE:BMY)Fred Alger Management LLC increased its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 146.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 102,293 shares of the biopharmaceutical company's stockDecember 1 at 5:45 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Sold by Quantbot Technologies LPQuantbot Technologies LP lowered its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 86.3% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 25,387 shares of the biopharmaceutical company's stock afterDecember 1 at 4:01 AM | marketbeat.comEdgestream Partners L.P. Boosts Holdings in Bristol-Myers Squibb (NYSE:BMY)Edgestream Partners L.P. lifted its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 842.9% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 158,123 shares of the biopharmaceutical company's stock afNovember 30 at 8:54 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Sold by Point72 Europe London LLPPoint72 Europe London LLP cut its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 29.4% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 55,851 shares of the biopharmaceutical company's stock after selling 23,252 shares dNovember 30 at 8:07 AM | marketbeat.comCaisse DE Depot ET Placement DU Quebec Raises Stake in Bristol-Myers Squibb (NYSE:BMY)Caisse DE Depot ET Placement DU Quebec lifted its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 16.0% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,282,297 shares of the biopharmaceutiNovember 30 at 7:54 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Position Lifted by Captrust Financial AdvisorsCaptrust Financial Advisors raised its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 13.4% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 468,106 shares of the biopharmaceutical company's stock after purchasing an additional 55,134 shares during theNovember 30 at 6:38 AM | marketbeat.comRockefeller Capital Management L.P. Sells 10,785 Shares of Bristol-Myers Squibb (NYSE:BMY)Rockefeller Capital Management L.P. decreased its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 1.2% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 916,240 shares of the biopharmaceutical company's stock after sNovember 30 at 6:20 AM | marketbeat.comMartingale Asset Management L P Has $11.89 Million Holdings in Bristol-Myers Squibb (NYSE:BMY)Martingale Asset Management L P cut its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 10.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 229,857 shares of the biopharmaceutical company's stock after selling 25,424 shares during tNovember 30 at 6:11 AM | marketbeat.comFreedom Investment Management Inc. Lowers Position in Bristol-Myers Squibb (NYSE:BMY)Freedom Investment Management Inc. decreased its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 67.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,766 shares of the biopharmNovember 30 at 4:39 AM | marketbeat.comBristol-Myers Squibb Files Lawsuit Against US Agency For Overreach In 340B Drug Pricing ProgramNovember 29 at 1:03 PM | benzinga.comBristol-Myers Squibb (NYSE:BMY) Shares Sold by Vestal Point Capital LPVestal Point Capital LP cut its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 50.0% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 250,000 shares of the biopharmacNovember 29 at 8:19 AM | marketbeat.com3 Magnificent S&P 500 Dividend Stocks Down 27%, 28%, and 29% to Buy and Hold ForeverNovember 29 at 6:11 AM | fool.comVinva Investment Management Ltd Purchases 17,231 Shares of Bristol-Myers Squibb (NYSE:BMY)Vinva Investment Management Ltd increased its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 15.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 132,101 shares of the biopharmaceutical company's stock afNovember 28 at 9:44 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 18.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owNovember 28 at 9:10 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Sold by Zurcher Kantonalbank Zurich CantonalbankZurcher Kantonalbank Zurich Cantonalbank lowered its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 2.6% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,392,991 shares of the biophaNovember 28 at 8:21 AM | marketbeat.comBridgewater Associates LP Purchases 55,364 Shares of Bristol-Myers Squibb (NYSE:BMY)Bridgewater Associates LP grew its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 10.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 610,358 shares of the biopharmaceutical company's stocNovember 28 at 6:48 AM | marketbeat.comTownsquare Capital LLC Has $7.75 Million Stake in Bristol-Myers Squibb (NYSE:BMY)Townsquare Capital LLC grew its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 20.4% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 149,694 shares of the biopharmaceutical company's stock after purchasingNovember 28 at 6:30 AM | marketbeat.comThe Manufacturers Life Insurance Company Increases Stake in Bristol-Myers Squibb (NYSE:BMY)The Manufacturers Life Insurance Company boosted its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 1.8% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 1,711,074 shares of the biopharmaceutical company's stock after purchasing anNovember 28 at 5:29 AM | marketbeat.comMetLife Investment Management LLC Decreases Stake in Bristol-Myers Squibb (NYSE:BMY)MetLife Investment Management LLC lessened its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 2.5% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 527,202 shares of the biopharmaceutical companNovember 27, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Purchased by BNP ParibasBNP Paribas boosted its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 258.4% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 39,463 shares of the biopharmaceuticalNovember 27, 2024 | marketbeat.comGlenmede Trust Co. NA Lowers Position in Bristol-Myers Squibb (NYSE:BMY)Glenmede Trust Co. NA lowered its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 23.9% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 943,271 shares of the biopharmaceutical compaNovember 27, 2024 | marketbeat.comDai ichi Life Insurance Company Ltd Has $3.43 Million Stock Position in Bristol-Myers Squibb (NYSE:BMY)Dai ichi Life Insurance Company Ltd grew its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 308.7% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 66,197 shares of the biopharmaceuticaNovember 27, 2024 | marketbeat.comQsemble Capital Management LP Sells 12,253 Shares of Bristol-Myers Squibb (NYSE:BMY)Qsemble Capital Management LP cut its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 48.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,132 shares of the biopharmaceutical compaNovember 27, 2024 | marketbeat.comLoomis Sayles & Co. L P Has $14.36 Million Stake in Bristol-Myers Squibb (NYSE:BMY)Loomis Sayles & Co. L P grew its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 29.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 277,599 shares of the biopharmaceutical company's stNovember 27, 2024 | marketbeat.comPrincipal Street Partners LLC Decreases Stake in Bristol-Myers Squibb (NYSE:BMY)Principal Street Partners LLC lessened its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 10.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 118,215 shares of the biopharmaceuNovember 26, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Sold by D.A. Davidson & CO.D.A. Davidson & CO. lessened its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 8.7% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 378,934 shares of the biopharmaceutical company's stock after seNovember 26, 2024 | marketbeat.comFmr LLC Increases Stake in Bristol-Myers Squibb (NYSE:BMY)Fmr LLC boosted its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 10.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 44,940,609 shares of the biopharmaceutical company's stock after purchasing an additiNovember 26, 2024 | marketbeat.comEagle Asset Management Inc. Purchases Shares of 54,691 Bristol-Myers Squibb (NYSE:BMY)Eagle Asset Management Inc. acquired a new position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 54,691 shares of the biopharmaceutical company's stock, valued at approximately $November 26, 2024 | marketbeat.com5 Reasons Bristol-Myers Squibb Looks Good Now (Rating Upgrade)November 25, 2024 | seekingalpha.comOne Sector Has Underperformed Massively: These 4 Blue-Chip Dividend Giants Are Huge 2025 PlaysNovember 25, 2024 | 247wallst.comAssociated Banc Corp Sells 14,083 Shares of Bristol-Myers Squibb (NYSE:BMY)Associated Banc Corp reduced its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 8.6% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 148,784 shares of the biopharmaceutical company's stock after selling 14,0November 25, 2024 | marketbeat.comHorizon Kinetics Asset Management LLC Purchases 14,364 Shares of Bristol-Myers Squibb (NYSE:BMY)Horizon Kinetics Asset Management LLC raised its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 31.9% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 59,382 shares of the biopharmaceuticalNovember 25, 2024 | marketbeat.comHancock Whitney Corp Grows Stake in Bristol-Myers Squibb (NYSE:BMY)Hancock Whitney Corp grew its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 1,213.3% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 319,008 shares of the biopharmaceutical company's stock after buying an additional 294,717November 25, 2024 | marketbeat.comOptimistic Buy Rating for Bristol-Myers Squibb Driven by Promising Cobenfy Projections and Competitive AdvantagesNovember 25, 2024 | markets.businessinsider.comDaiwa Securities Group Inc. Purchases 78,309 Shares of Bristol-Myers Squibb (NYSE:BMY)Daiwa Securities Group Inc. grew its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 31.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 330,191 shares of the biopharmaceutical company's stock after purchasing anNovember 25, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Bought by Algert Global LLCAlgert Global LLC lifted its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 1,157.5% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 99,356 shares of the biopharmaceutical company's stock after purchasing an additional 91,455 shNovember 25, 2024 | marketbeat.com69,171 Shares in Bristol-Myers Squibb (NYSE:BMY) Purchased by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. bought a new position in Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 69,171 shares of the biopharmaceutical companNovember 25, 2024 | marketbeat.comSompo Asset Management Co. Ltd. Has $2.58 Million Position in Bristol-Myers Squibb (NYSE:BMY)Sompo Asset Management Co. Ltd. increased its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 43.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 49,780 shares of the biopharmaceutical company's stock after purchasing an aNovember 24, 2024 | marketbeat.comWhere Will Bristol Myers Squibb Be in 5 Years?November 24, 2024 | fool.comKingsview Wealth Management LLC Purchases 61,943 Shares of Bristol-Myers Squibb (NYSE:BMY)Kingsview Wealth Management LLC lifted its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 189.1% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 94,694 shares of the biopharmaceutical company's stock after purchasing an additionaNovember 24, 2024 | marketbeat.comCerity Partners LLC Has $46.12 Million Holdings in Bristol-Myers Squibb (NYSE:BMY)Cerity Partners LLC increased its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 38.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 891,305 shares of the biopharmaceutical companyNovember 24, 2024 | marketbeat.com17,922 Shares in Bristol-Myers Squibb (NYSE:BMY) Acquired by Nwam LLCNwam LLC acquired a new stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 17,922 shares of the biopharmaceutical company's stock, valued at approximatNovember 24, 2024 | marketbeat.comMeridian Wealth Management LLC Buys New Position in Bristol-Myers Squibb (NYSE:BMY)Meridian Wealth Management LLC bought a new stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 51,830 shares of the biopharmaceutical company's stock, valued at approximately $2,6November 23, 2024 | marketbeat.comQuest Partners LLC Decreases Stake in Bristol-Myers Squibb (NYSE:BMY)Quest Partners LLC trimmed its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 70.3% in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 12,156 shares of the biopharmaceutical company's stock after selling 28,722 shares during the quaNovember 23, 2024 | marketbeat.comValence8 US LP Takes $920,000 Position in Bristol-Myers Squibb (NYSE:BMY)Valence8 US LP bought a new stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 17,785 shares of the biopharmaceutical company's stock, valued at approximNovember 22, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Sold by Mizuho Securities USA LLCMizuho Securities USA LLC trimmed its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 15.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 131,466 shares of the biopharmaceutical company's stock afteNovember 22, 2024 | marketbeat.comBNP PARIBAS ASSET MANAGEMENT Holding S.A. Trims Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)BNP PARIBAS ASSET MANAGEMENT Holding S.A. decreased its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 13.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 984,246 shares oNovember 22, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Receives $54.07 Average PT from AnalystsNovember 22, 2024 | americanbankingnews.com Get Bristol-Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Is Mocking Elon, But Wait Until They See This Demo (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it. Click here to watch this demo and decide for yourself. BMY Media Mentions By Week BMY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMY News Sentiment▼1.350.87▲Average Medical News Sentiment BMY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMY Articles This Week▼4026▲BMY Articles Average Week Get Bristol-Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Johnson & Johnson News Today AbbVie News Today Merck & Co., Inc. News Today Pfizer News Today Zoetis News Today Royalty Pharma News Today Jazz Pharmaceuticals News Today Corcept Therapeutics News Today Perrigo News Today Supernus Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BMY) was last updated on 12/1/2024 by MarketBeat.com Staff From Our PartnersThe latest trend in real estateThese vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, t...Pacaso | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredBofA is watching for a market topU.S. tech stocks have soared so high for so long that they're no longer just minting new millionaires... Th...Chaikin Analytics | SponsoredPaypal, Tesla, SpaceX… Elon's next project is bigger than them allIn February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored***TODAY ONLY*** Is this Trump’s Favorite Coin?Donald Trump just emphatically became America's first crypto president. Trump plans to make America, "the...Weiss Ratings | SponsoredThis Crisis Could Be Worse Than 2008Underneath the surface, cracks are forming. Cracks that threaten to shatter everything we know. America ...Behind the Markets | SponsoredYou’re invited! See my NEWEST trading strategyThis could easily be the most lucrative new trading strategy of 2025... So you’re not going to want to miss...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bristol-Myers Squibb Please log in to your account or sign up in order to add this asset to your watchlist. Share Bristol-Myers Squibb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
